English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Eli Lilly And Company
Patient Daily
| May 25, 2023
Lilly ESG Report Highlights Progress Towards Sustainability Goals
Patient Daily
| May 24, 2023
Lilly's peresolimab Phase 2a rheumatoid arthritis trial published in The New England Journal of Medicine
Patient Daily
| May 22, 2023
Loxo@Lilly Announces Details of Presentations at 2023 European Hematology Association (EHA) Annual Meeting
Patient Daily
| May 9, 2023
Lilly Provides $500,000 in Grants to Support Equitable Access to Education for Dreamers in Indiana
Patient Daily
| May 9, 2023
Lilly Declares Second-Quarter 2023 Dividend
Patient Daily
| May 9, 2023
Lilly's tirzepatide achieved up to 15.7% weight loss in adults with obesity or overweight and type 2 diabetes in SURMOUNT-2
Patient Daily
| Apr 26, 2023
Lilly to Divest BAQSIMI to Amphastar
Patient Daily
| Apr 26, 2023
Lilly to Make Record-Breaking Investment in Indiana Manufacturing Facilities
Trending
Patient Daily
| Sep 3, 2025
Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+
Pharmaceuticals
Patient Daily
| Sep 4, 2025
PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+
Pharmaceuticals
Patient Daily
| Aug 29, 2025
Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
+
Pharmaceuticals
Patient Daily
| Sep 2, 2025
Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
1
2
3
»
Last »